PLRX Archived Articles
PLIANT THERAPEUTICS (PLRX): A Clinical-Stage Leader in Fibrotic Disease Therapies
Published on March 14, 2025
Pliant Therapeutics, Inc. (NASDAQ:PLRX): A Promising Biopharmaceutical Company Advancing Novel Therapies for Fibrotic Diseases
Published on September 24, 2024